Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1984 Dec;52(6):628–632. doi: 10.1136/hrt.52.6.628

Effect of timolol maleate on pacing induced myocardial ischaemia.

K Daly, P J Richardson, G Bergman, L Atkinson, S Kerkez, D E Jewitt
PMCID: PMC481696  PMID: 6508963

Abstract

The effects of timolol maleate administered intravenously on coronary and systemic haemodynamics, myocardial metabolism, and plasma catecholamine concentrations were assessed in 10 patients with confirmed coronary artery disease. Rapid atrial pacing to the onset of angina was performed in all patients. Timolol reduced cardiac output at rest and during pacing and reduced resting heart rate but did not affect arterial blood pressure. Left ventricular stroke work index fell during pacing. Coronary sinus blood flow was unchanged, but pulmonary artery diastolic pressure rose after timolol. The drug produced clinical improvement in nine of the 10 patients with prolongation of the mean pacing time to angina. There was evidence of improved myocardial metabolism with a change from production to extraction of lactate: Arterial noradrenaline concentrations at rest rose after timolol. In these patients with coronary artery disease timolol produced an increased tolerance to atrial pacing stress, which appears to be due to a combination of effects including reduced myocardial contractility and decreased lipolysis.

Full text

PDF
628

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong P. W., Chiong M. A., Parker J. O. Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacing. Am J Cardiol. 1977 Jul;40(1):83–89. doi: 10.1016/0002-9149(77)90105-9. [DOI] [PubMed] [Google Scholar]
  2. Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol. 1971 Apr;27(4):416–432. doi: 10.1016/0002-9149(71)90439-5. [DOI] [PubMed] [Google Scholar]
  3. Deacon S. P. The effects of atenolol and propranolol upon lipolysis. Br J Clin Pharmacol. 1978 Feb;5(2):123–125. doi: 10.1111/j.1365-2125.1978.tb01611.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Epstein S. E., Braunwald E. Inhibition of the adrenergic nervous system in the treatment of angina pectoris. Med Clin North Am. 1968 Sep;52(5):1031–1039. [PubMed] [Google Scholar]
  5. Frishman W., Kostis J., Strom J., Hossler M., Elkayam U., Goldner S., Silverman R., Davis R., Weinstein J., Sonnenblick E. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity. Am Heart J. 1979 Oct;98(4):526–535. doi: 10.1016/0002-8703(79)90261-8. [DOI] [PubMed] [Google Scholar]
  6. Ganz W., Tamura K., Marcus H. S., Donoso R., Yoshida S., Swan H. J. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation. 1971 Aug;44(2):181–195. doi: 10.1161/01.cir.44.2.181. [DOI] [PubMed] [Google Scholar]
  7. Hansen J. F., Hesse B., Christensen N. J. Enhanced sympathetic nervous activity after intravenous propranolol in ischaemic heart disease: plasma noradrenaline splanchnic blood flow and mixed venous oxygen saturation at rest and during exercise. Eur J Clin Invest. 1978 Feb;8(1):31–36. doi: 10.1111/j.1365-2362.1978.tb00805.x. [DOI] [PubMed] [Google Scholar]
  8. Harris F. J., Low R. I., Paumer L., Amsterdam E. A., Mason D. T. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease. Am J Cardiol. 1983 Jan 1;51(1):13–18. doi: 10.1016/s0002-9149(83)80004-6. [DOI] [PubMed] [Google Scholar]
  9. Harris F. J., Tonkin M., Pratt C., DeMaria A. N., Amsterdam E. A., Mason D. T. Short- and long-term therapy of mild essential hypertension with timolol. Clin Pharmacol Ther. 1981 Dec;30(6):765–772. doi: 10.1038/clpt.1981.236. [DOI] [PubMed] [Google Scholar]
  10. Henry D. P., Starman B. J., Johnson D. G., Williams R. H. A sensitive radioenzymatic assay for norepinephrine in tissues and plasma. Life Sci. 1975 Feb 1;16(3):375–384. doi: 10.1016/0024-3205(75)90258-1. [DOI] [PubMed] [Google Scholar]
  11. Holmberg S., Varnauskas E. Coronary circulation during pacing-induced tachycardia. Acta Med Scand. 1971 Dec;190(6):481–490. doi: 10.1111/j.0954-6820.1971.tb07463.x. [DOI] [PubMed] [Google Scholar]
  12. Lauwerys R. R. Colorimetric determination of free fatty acids. Anal Biochem. 1969 Nov;32(2):331–333. doi: 10.1016/0003-2697(69)90093-1. [DOI] [PubMed] [Google Scholar]
  13. Lech J. J., Jesmok G. J., Calvert D. N. Effects of drugs and hormones on lipolysis in heart. Fed Proc. 1977 Jun;36(7):2000–2008. [PubMed] [Google Scholar]
  14. Livesley B., Atkinson L. Letter: Accurate quantitative estimation of lactate in whole blood. Clin Chem. 1974 Nov;20(11):1478–1478. [PubMed] [Google Scholar]
  15. MAGER M., FARESE G. WHAT IS "TRUE" BLOOD GLUCOSE?A COMPARISON OF THREE PROCEDURES. Am J Clin Pathol. 1965 Jul;44:104–108. [PubMed] [Google Scholar]
  16. Miller R. R., Olson H. G., Pratt C. M., Amsterdam E. Z., Mason D. T. Efficacy of beta adrenergic blockade in coronary heart disease: propranolol in angina pectoris. Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):598–605. doi: 10.1002/cpt1975185part1598. [DOI] [PubMed] [Google Scholar]
  17. Mueller H. S., Rao P. S., Rao P. B., Gory D. J., Mudd J. G., Ayres S. M. Enhanced transcardiac l-norepinephrine response during cold pressor test in obstructive coronary artery disease. Am J Cardiol. 1982 Dec;50(6):1223–1228. doi: 10.1016/0002-9149(82)90453-2. [DOI] [PubMed] [Google Scholar]
  18. Pilkington T. R., Lowe R. D., Foster R., Robinson B. F., Antonis A. Effect of sympathomimetic compounds with beta-adrenergic effects on plasma free fatty acids in man. J Lipid Res. 1966 Jan;7(1):73–76. [PubMed] [Google Scholar]
  19. Pitt B., Craven P. Effect of propranolol on regional myocardial blood flow in acute ischaemia. Cardiovasc Res. 1970 Apr;4(2):176–179. doi: 10.1093/cvr/4.2.176. [DOI] [PubMed] [Google Scholar]
  20. Rahn K. H., Gierlichs H. W., Planz G., Planz R., Schols M., Stephany W. Studies on the effects of propanolol on plasma catecholamine levels in patients with essential hypertension. Eur J Clin Invest. 1978 Jun;8(3):143–148. doi: 10.1111/j.1365-2362.1978.tb00827.x. [DOI] [PubMed] [Google Scholar]
  21. Scriabine A., Torchiana M. L., Stavorski J. M., Ludden C. T., Minsker D. H., Stone C. A. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent. Arch Int Pharmacodyn Ther. 1973 Sep;205(1):76–93. [PubMed] [Google Scholar]
  22. Thompson D. S., Naqvi N., Juul S. M., Coltart D. J., Jenkins B. S., Webb-Peploe M. M. Haemodynamic and metabolic effects of atenolol in patients with angina pectoris. Br Heart J. 1980 Jun;43(6):668–679. doi: 10.1136/hrt.43.6.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wilhelmsson C., Vedin J. A., Wilhelmsen L., Tibblin G., Werkö L. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet. 1974 Nov 16;2(7890):1157–1160. doi: 10.1016/s0140-6736(74)90807-1. [DOI] [PubMed] [Google Scholar]
  24. Wolfson S., Gorlin R. Cardiovascular pharmacology of propranolol in man. Circulation. 1969 Oct;40(4):501–511. doi: 10.1161/01.cir.40.4.501. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES